PV-GP-40P | |
Name | Membrane Glycoprotein G1 of Phlebovirus (SFTS Virus HN6) |
Description | C-terminal 6xHis tagged Phlebovirus membrane glycoprotein G1 (amino acid 20-452) (SFTS virus HN6) (GenBank No. ADZ04490) |
Source | Glycosylated recombinant viral protein purified from 293 cell cells |
Application | Western blot standard, antibody ELISA, immunogen, etc. |
Purity | > 95% (SDS-PAGE) |
Size | 50 µg |
eEnzyme是一家美国高质量生物学试剂及检测试剂盒品牌供应商,其与美国国立卫生研究院合作紧密,在全球范围内为广大科研客户提供高品质的产品与技术服务,其主要生产销售高质量的抗体和用于传染病研究的抗体/抗原,细胞因子蛋白,pcr产品等用于分子和细胞生物学研究的生物试剂,产品应用于生物技术研究,制药,药物发现,癌症研究,传染性疾病,微生物和分子诊断等众多生命科学技术领域
eENZYME为科学界生产和销售高质量的生物试剂盒和生物分析试剂盒。与NIH密切合作以保证产品在生命科学研究的多个领域成功地使用。努力提供新颖价廉且有效的工具,使实验更容易成功。产品在科研、生物技术、制药和政府的研究实验室中得到广泛的应用,包括药物发现、癌症研究、传染病研究、微生物学和分子诊断。
【简单介绍】eENZYME生产销售高质量的抗体和用于传染病研究的抗体/抗原,细胞因子蛋白,PCR产品等用于分子和细胞生物学研究的生物试剂,产品应用于生物技术研究,制药,药物发现,癌症研究,传染性疾病,微生物和分子诊断等众多生命科学技术领域。【详细说明】欢迎eENZYMEeENZYME生产销售高质量的抗体和用于传染病研究的抗体/抗原,细胞因子蛋白,PCR产品等用于分子和细胞生物学研究的生物试剂,产品应用于生物技术研究,制药,药物发现,癌症研究,传染性疾病,微生物和分子诊断等众多生命科学技术领域。 Ë ENZYMEis的高品质生物试剂及实验室设备科学界一个制造商和分销商。我们密切合作,与美国国立卫生研究院的社区,以保证我们的产品生命科学研究在广泛领域的成功表现。我们致力于提供创新和具有成本效益的工具,使您更容易取得成功。我们的产品用于在学术,生物技术,制药和政府研究实验室,包括药物发现,癌症研究,传染病研究,微生物学和分子诊断许多不同的应用。公司网站:www.eenzyme.com 目录号描述产品类型应用单位供应商IA-01SW-0100抗HA(A/California/06/09)(甲型H1N1流感)兔多克隆抗体WB等100微克eENZYMEIA-011-0100抗H1(H1N1/Pan)兔多克隆抗体WB等100微克eENZYMEIA-001-0100抗HA1(A/新喀里多尼亚)(甲型H1N1流感)兔多克隆抗体WB等100微克eENZYMEIA-023-0100抗-NP(A/新Caledonia/20/1999)(甲型H1N1流感兔多克隆抗体WB等100微克eENZYMEIA-022-0100抗M2型(H1N1/A/新喀里多尼亚(H1N1))兔多克隆抗体WB等100微克eENZYMEIA-004A-0100抗-H3(H3N2)(A/WIS/2005)兔多克隆抗体WB等100微克eENZYMEIA-003-0100抗-M1(H3N2)[A/Wyoming/3/03)兔多克隆抗体WB等100微克eENZYMEIA-004-0100抗HA(H3N2)[A/Wyoming/3/03)兔多克隆抗体WB等100微克eENZYMEIA-020-0100抗-NA(H3N2)[A/Wyoming/3/03)兔多克隆抗体WB等100微克eENZYMEIA-005H-0100抗H5(A/香港Kong/483/97)(H5N1)兔多克隆抗体WB等100微克eENZYMEIA-005-0100抗HA1(H5N1)(A/Vietnam/1203/2004)兔多克隆抗体WB等100微克eENZYMEIA-006-0100抗HA1(H5N1,禽流感)(A/斑头雁/Qinghai/12/05)兔多克隆抗体WB等100微克eENZYMEIA-010-0100抗-HA2(A/Vietnam/1203/2004)(H5N1)兔多克隆抗体WB等100微克eENZYMEIA-012-0100抗-M1(A/Vietnam/1203/2004)(H5N1)兔多克隆抗体WB等100微克eENZYMEIA-021-0100抗-NA(A/Vietnam/1203/2004)(H5N1,人)兔多克隆抗体WB等100微克eENZYMEIA-025-0100抗NS1(A/Vietnam/1203/2004)(H5N1)兔多克隆抗体WB等100微克eENZYMEIA-003-0100抗HA1(A/Chicken/NY/29878/91)(H2N2)兔多克隆抗体WB等100微克eENZYMEIA-009-0100抗HA1(A/chicken/HongKong/NT366/03)(H9N2)兔多克隆抗体WB等100微克eENZYMEIA-027-0100抗-NA(A/Chicken/HongKong/NT366/03)(H9N2)兔多克隆抗体WB等100微克eENZYMEIA-007-0100抗HA1(A/duck/Hainan/6/2004)(H6N2)兔多克隆抗体WB等100微克eENZYMEIA-008-0100抗HA1(A/鸡/荷兰/2/03)兔多克隆抗体WB等100微克eENZYMEIA-028-0100抗-NA(A/Chicken/Netherlands/1/03)(H7N7)兔多克隆抗体WB等100微克eENZYMEIA-0015-0100抗-H11(A/duck/Yangzhou/906/02)(H11N2)兔多克隆抗体WB等100微克eENZYMEIA-003-0031抗B型流感(NP)的多克隆兔多克隆抗体WB等100微克eENZYMEIA-003-0032抗B型流感(医管局)多克隆兔多克隆抗体WB等100微克eENZYMEIA-013-0100抗-H12(A/pintail/Alaska/102/05)(H12N5)兔多克隆抗体WB等100微克eENZYMEIA-014-0100抗-H4(A/environment/Maryland/1101/06)(H4N6)兔多克隆抗体WB等100微克eENZYMEIA-003-018抗-H15(A/Australia/83/00(H15N8))兔多克隆抗体WB等100微克eENZYMEIA-003-019抗-H16(A/Sweden/99(H16N3))兔多克隆抗体WB等100微克eENZYME目录号描述产品类型应用单位供应商IA-01SW-0100抗HA(A/California/06/09)(甲型H1N1流感)兔多克隆抗体WB等100微克eENZYMEIA-011-0100抗H1(H1N1/Pan)兔多克隆抗体WB等100微克eENZYMEIA-001-0100抗HA1(A/新喀里多尼亚)(甲型H1N1流感)兔多克隆抗体WB等100微克eENZYMEIA-023-0100抗-NP(A/新Caledonia/20/1999)(甲型H1N1流感兔多克隆抗体WB等100微克eENZYMEIA-022-0100抗M2型(H1N1/A/新喀里多尼亚(H1N1))兔多克隆抗体WB等100微克eENZYMEIA-004A-0100抗-H3(H3N2)(A/WIS/2005)兔多克隆抗体WB等100微克eENZYMEIA-003-0100抗-M1(H3N2)[A/Wyoming/3/03)兔多克隆抗体WB等100微克eENZYMEIA-004-0100抗HA(H3N2)[A/Wyoming/3/03)兔多克隆抗体WB等100微克eENZYMEIA-020-0100抗-NA(H3N2)[A/Wyoming/3/03)兔多克隆抗体WB等100微克eENZYMEIA-005H-0100抗H5(A/香港Kong/483/97)(H5N1)兔多克隆抗体WB等100微克eENZYMEIA-005-0100抗HA1(H5N1)(A/Vietnam/1203/2004)兔多克隆抗体WB等100微克eENZYMEIA-006-0100抗HA1(H5N1,禽流感)(A/斑头雁/Qinghai/12/05)兔多克隆抗体WB等100微克eENZYMEIA-010-0100抗-HA2(A/Vietnam/1203/2004)(H5N1)兔多克隆抗体WB等100微克eENZYMEIA-012-0100抗-M1(A/Vietnam/1203/2004)(H5N1)兔多克隆抗体WB等100微克eENZYMEIA-021-0100抗-NA(A/Vietnam/1203/2004)(H5N1,人)兔多克隆抗体WB等100微克eENZYMEIA-025-0100抗NS1(A/Vietnam/1203/2004)(H5N1)兔多克隆抗体WB等100微克eENZYMEIA-003-0100抗HA1(A/Chicken/NY/29878/91)(H2N2)兔多克隆抗体WB等100微克eENZYMEIA-009-0100抗HA1(A/chicken/HongKong/NT366/03)(H9N2)兔多克隆抗体WB等100微克eENZYMEIA-027-0100抗-NA(A/Chicken/HongKong/NT366/03)(H9N2)兔多克隆抗体WB等100微克eENZYMEIA-007-0100抗HA1(A/duck/Hainan/6/2004)(H6N2)兔多克隆抗体WB等100微克eENZYMEIA-008-0100抗HA1(A/鸡/荷兰/2/03)兔多克隆抗体WB等100微克eENZYMEIA-028-0100抗-NA(A/Chicken/Netherlands/1/03)(H7N7)兔多克隆抗体WB等100微克eENZYMEIA-0015-0100抗-H11(A/duck/Yangzhou/906/02)(H11N2)兔多克隆抗体WB等100微克eENZYMEIA-003-0031抗B型流感(NP)的多克隆兔多克隆抗体WB等100微克eENZYMEIA-003-0032抗B型流感(医管局)多克隆兔多克隆抗体WB等100微克eENZYMEIA-013-0100抗-H12(A/pintail/Alaska/102/05)(H12N5)兔多克隆抗体WB等100微克eENZYMEIA-014-0100抗-H4(A/environment/Maryland/1101/06)(H4N6)兔多克隆抗体WB等100微克eENZYMEIA-003-018抗-H15(A/Australia/83/00(H15N8))兔多克隆抗体WB等100微克eENZYMEIA-003-019抗-H16(A/Sweden/99(H16N3))兔多克隆抗体WB等100微克eENZYME目录号描述产品类型应用单位供应商IA-01SW-0100抗HA(A/California/06/09)(甲型H1N1流感)兔多克隆抗体WB等100微克eENZYMEIA-011-0100抗H1(H1N1/Pan)兔多克隆抗体WB等100微克eENZYMEIA-001-0100抗HA1(A/新喀里多尼亚)(甲型H1N1流感)兔多克隆抗体WB等100微克eENZYMEIA-023-0100抗-NP(A/新Caledonia/20/1999)(甲型H1N1流感兔多克隆抗体WB等100微克eENZYMEIA-022-0100抗M2型(H1N1/A/新喀里多尼亚(H1N1))兔多克隆抗体WB等100微克eENZYMEIA-004A-0100抗-H3(H3N2)(A/WIS/2005)兔多克隆抗体WB等100微克eENZYMEIA-003-0100抗-M1(H3N2)[A/Wyoming/3/03)兔多克隆抗体WB等100微克eENZYMEIA-004-0100抗HA(H3N2)[A/Wyoming/3/03)兔多克隆抗体WB等100微克eENZYMEIA-020-0100抗-NA(H3N2)[A/Wyoming/3/03)兔多克隆抗体WB等100微克eENZYMEIA-005H-0100抗H5(A/香港Kong/483/97)(H5N1)兔多克隆抗体WB等100微克eENZYMEIA-005-0100抗HA1(H5N1)(A/Vietnam/1203/2004)兔多克隆抗体WB等100微克eENZYMEIA-006-0100抗HA1(H5N1,禽流感)(A/斑头雁/Qinghai/12/05)兔多克隆抗体WB等100微克eENZYMEIA-010-0100抗-HA2(A/Vietnam/1203/2004)(H5N1)兔多克隆抗体WB等100微克eENZYMEIA-012-0100抗-M1(A/Vietnam/1203/2004)(H5N1)兔多克隆抗体WB等100微克eENZYMEIA-021-0100抗-NA(A/Vietnam/1203/2004)(H5N1,人)兔多克隆抗体WB等100微克eENZYMEIA-025-0100抗NS1(A/Vietnam/1203/2004)(H5N1)兔多克隆抗体WB等100微克eENZYMEIA-003-0100抗HA1(A/Chicken/NY/29878/91)(H2N2)兔多克隆抗体WB等100微克eENZYMEIA-009-0100抗HA1(A/chicken/HongKong/NT366/03)(H9N2)兔多克隆抗体WB等100微克eENZYMEIA-027-0100抗-NA(A/Chicken/HongKong/NT366/03)(H9N2)兔多克隆抗体WB等100微克eENZYMEIA-007-0100抗HA1(A/duck/Hainan/6/2004)(H6N2)兔多克隆抗体WB等100微克eENZYMEIA-008-0100抗HA1(A/鸡/荷兰/2/03)兔多克隆抗体WB等100微克eENZYMEIA-028-0100抗-NA(A/Chicken/Netherlands/1/03)(H7N7)兔多克隆抗体WB等100微克eENZYMEIA-0015-0100抗-H11(A/duck/Yangzhou/906/02)(H11N2)兔多克隆抗体WB等100微克eENZYMEIA-003-0031抗B型流感(NP)的多克隆兔多克隆抗体WB等100微克eENZYMEIA-003-0032抗B型流感(医管局)多克隆兔多克隆抗体WB等100微克eENZYMEIA-013-0100抗-H12(A/pintail/Alaska/102/05)(H12N5)兔多克隆抗体WB等100微克eENZYMEIA-014-0100抗-H4(A/environment/Maryland/1101/06)(H4N6)兔多克隆抗体WB等100微克eENZYMEIA-003-018抗-H15(A/Australia/83/00(H15N8))兔多克隆抗体WB等100微克eENZYMEIA-003-019抗-H16(A/Sweden/99(H16N3))兔多克隆抗体WB等100微克eENZYME
ebiomall.com
>
>
>
>
>
>
>
>
>
>
>
>
我想在体外培养的细胞中,加入PD-L1重组蛋白,激活PD-L1:PD-1通路,但我没能查到相关的文献,不清楚PD-L1重组蛋白的用量。请问各位有相关的经验吗?或者阅读过相关的文献?
定量:考马斯亮蓝显色或紫外分光光度计,就是光谱学的方法。
人类医学发展到今天,对某些疑难疾病还是不能彻底根治,如遗传疾病,器官坏死,和糖尿病等。这些疾病仅靠药物治疗只能减缓症状,而器官移植又受捐赠器官有限和免疫排斥等因素的限制而不能推广。干细胞是唯一有可能攻克这些疾病的治疗手段。但长期以来,获取多能干细胞(pluripotentstemcell)的主要来源为人的胚胎。这引起道德和宗教的争议,进而在美国等国家受到法律限制。另外,用异己的胚胎干细胞发展的治疗手段将来还是会遇到免疫排斥的问题。
2006年,日本科学家ShinyaYamanaka领导的实验室第一次证明,通过以反转录病毒为载体转基因表达四个转录因子,可以将小鼠或人的体细胞转变为与胚胎干细胞拥有相似分化和繁殖能力的细胞,命名为诱导性干细胞(iPS)。这一成果具有划时代的意义:1)干细胞的产生可以不再需要破坏胚胎,避免了道德,宗教和法律上的限制;2)不同疾病的诱导性干细胞可衍生出不同类型的疾病模型,为基础研究和药物筛选提供了强大的武器;3)理论上,各种疑难疾病可以通过病人自己的体细胞转变为干细胞,再分化为各种类型的细胞,组织,甚至器官,经过或不经过体外加工后,放回病人体内,治愈疾病。
在本论文中,研究人员成功地用四个转录因子的蛋白完成了由体细胞到诱导性干细胞的转变过程。自始至终,细胞的遗传信息没有受到任何影响。蛋白诱导性干细胞的重大意义包括:1)安全性:转化过程没有使用病毒,没有使用基因,没有任何改变细胞遗传信息的风险;2)普及性:蛋白诱导方法远比基因诱导方法简单易行。这样一来,iPS技术不再被几个资深实验室所垄断。大部分实验室都可以重复蛋白方法而获得iPS。也就是说,蛋白诱导方法大大降低了iPS领域的"门坎"。3)可行性:由于该方法的简单易行,重复性强,它可以被扩大化,产业化,进而被商业化。蛋白诱导干细胞方法将大大降低利用干细胞对病人"量身定做"的治疗手段的成本,使得这一商业模式成为可能。
如果说,ShinyaYamanaka博士的成果第一次使人类看到了一个梦想,那么这篇论文的发表标志着我们从梦想向现实跨出了关键的一大步。
CellStemCell,23April2009doi:10.1016/j.stem.2009.04.005
GenerationofInducedPluripotentStemCellsUsingRecombinantProteins
HongyanZhou1,ShiliWu4,7,JinYoungJoo5,7,SaiyongZhu1,DongWookHan5,TongxiangLin1,SuniaTrauger2,3,GeofferyBien4,SusanYao4,YongZhu4,GarySiuzdak2,3,HansR.Sch?ler5,LingxunDuan6andShengDing1,,
1DepartmentofChemistry,TheScrippsResearchInstitute,10550NorthTorreyPinesRoad,LaJolla,CA92037,USA
2DepartmentofMolecularBIOLOGy,TheScrippsResearchInstitute,10550NorthTorreyPinesRoad,LaJolla,CA92037,USA
3CenterforMassSpectrometry,TheScrippsResearchInstitute,10550NorthTorreyPinesRoad,LaJolla,CA92037,USA
4ProteomTech,Inc.,3505CADIllacAvenue,SuiteF7,CostaMesa,CA92626,USA
5DepartmentofCellandDevelopmentalBiology,MaxPlanckInstituteforMolecularBiomedicine,R?ntgenstrasse20,Münster48149,Germany
6LD***aInc.,SandownWay,SanDiego,CA92130,USA
7Theseauthorscontributedequallytothiswork
Groundbreakingworkdemonstratedthatectopicexpressionoffourtranscriptionfactors,Oct4,Klf4,Sox2,andc-Myc,couldreprogrammurinesomaticcellstoinducedpluripotentstemcells(iPSCs)(TakahashiandYamanaka,2006),andhumaniPSCsweresubsequentlygeneratedusingsimilargeneticmanipulation(Takahashietal.,2007,Yuetal.,2007).Toaddressthesafetyissuesarosefromharboringintegratedexogenoussequencesinthetargetcellgenome,anumberofmodifiedgeneticmethodshavebeendevelopedandproducediPSCswithpotentiallyreducedrisks(fordiscussion,seeYamanaka,2009,andreferencestherein).However,allofthemethodsdevelopedtodatestillinvolvetheuseofgeneticmaterialsandthusthepotentialforunexpectedgeneticmodificationsbytheexogenoussequencesinthetargetcells.Herewereportgenerationofprotein-inducedpluripotentstemcells(piPSCs)frommurineembryonicfibroblastsusingrecombinantcell-penetratingreprogrammingproteins.WedemonstratedthatsuchpiPSCscanlong-termself-renewandarepluripotentinvitroandinvivo.
国内或者国外进口皆可!?看来你不缺钱啊!
这个问题问的过于笼统!
首先,蛋白表达与纯化包括很多种类型,比如原核蛋白表达,哺乳动物蛋白表达,酵母蛋白表达以及昆虫蛋白表达等等,而现在生物实验中常说的蛋白表达纯化通常是指利用大肠杆菌表达系统的原核蛋白表达,这种表达方式比较简单,普遍都可以做。但是如果是指很多种蛋白表达系统的话,可以做的单位就比较少了。
另外,蛋白的表达成功与否还需要取决于蛋白的性质,所以前期一定要问清楚!
开个贴,做好准备,已经有战友开始采用CTD格式写申报资料,大家多交流。
暂无品牌问答